Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Adaptive Decision Support for Addiction Treatment: Testing a Care Tool for ED Doctors to Help Buprenorphine Use

Official title: Adaptive Decision Support for Addiction Treatment (ADAPT) Serial Randomized Testing for Usability, Round 3

Run by Yale University · NCT07793383 · Data updated 2026-11-12

We’re testing a refined decision-support tool in emergency departments to help doctors prescribe buprenorphine to adults with moderate to severe opioid use disorder.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorYale University
Academic / other
Locations3 sites (Guilford, Connecticut and 2 other locations)
StatusRecruiting
StartedAugust 17, 2026
Main results expectedFebruary 2027
Study endsFebruary 2027
Registry record updatedSeptember 25, 2026
Trial IDNCT07793383 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 years or older presenting to an emergency department with moderate to severe opioid use disorder who are not currently receiving medication for opioid use disorder.

Probably not a fit

Patients already on optimized, fully integrated CDS workflows or those not eligible for buprenorphine initiation may derive little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project uses a multiphase optimization strategy to iteratively refine the EMBED CDS interface and workflow in real-time ED settings. Five rapid-cycle rounds compare variations of alerts and CDS components to reduce user errors and disruption while increasing adoption. The aim is to improve how ED physicians follow standard care for initiating buprenorphine in eligible patients. The study progresses through optimization and a follow-up confirmatory phase comparing the optimized system to the original EMBED package. Participating sites are in Connecticut, led by Yale University with NIDA collaboration.

Why it matters

Potential benefit: If successful, ED physicians may more reliably follow standard care for initiating buprenorphine, potentially improving treatment access for people with opioid use disorder.

How similar studies have gone: Previous work on EMBED CDS and related decision-support approaches has shown improvements in clinician workflow and adherence to recommended care, though this serial testing is a novel optimization effort.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Emergency department patient
* 18 years of age or older
* Moderate to severe opioid use disorder

Exclusion Criteria:

* Under 18 years of age
* Pregnant
* Currently receiving medication for opioid use disorder

Where it's running

  • Yale New Haven Shoreline Medical Center
    Guilford, Connecticut, United States
    Recruiting
  • Yale New Haven Hospital- St. Raphael
    New Haven, Connecticut, United States
    Recruiting
  • Yale New Haven Hospital
    New Haven, Connecticut, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.